Literature DB >> 1750765

Amniotic fluid N-acetyl-beta-D-glucosaminidase activity and renal abnormalities.

E Ring1, H Hofmann, W Erwa, M Riccabona, G Zobel, M Häusler.   

Abstract

Amniotic fluid N-acetyl-beta-D-glucosaminidase (NAG) activity was measured in 21 normal pregnancies to determine reference values, and in 10 pregnancies with fetuses who had prenatally recognised renal and urinary tract malformations. The normal values obtained at 17-19 and 28-31 gestational weeks did not differ, and an activity of 105 units NAG/mmol creatinine was the upper limit of the normal range. Raised NAG activities were found in four fetuses with oligohydramnios and severe bilateral renal disease, and also in two infants with a normal amount of amniotic fluid, only unilateral renal lesions, and a normal renal function after birth. Three of four cases with normal NAG activities had malformations without kidney damage, but one baby with prune belly syndrome was subsequently found to have dysplastic kidneys and renal failure. Our preliminary results suggest that a high level of NAG activity in the amniotic fluid indicates unilateral or bilateral kidney damage but is not proof of intrauterine renal failure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1750765      PMCID: PMC1590281          DOI: 10.1136/adc.66.10_spec_no.1147

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  Management of prenatally diagnosed uropathies.

Authors:  D F Thomas; A C Gordon
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

2.  Fetal urine-production rates in normal and complicated pregnancy.

Authors:  J W Wladimiroff; S Campbell
Journal:  Lancet       Date:  1974-02-02       Impact factor: 79.321

3.  Management of the fetus with congenital hydronephrosis II: Prognostic criteria and selection for treatment.

Authors:  P L Glick; M R Harrison; M S Golbus; N S Adzick; R A Filly; P W Callen; B S Mahony; R L Anderson; A A deLorimier
Journal:  J Pediatr Surg       Date:  1985-08       Impact factor: 2.545

4.  Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase in the general population and in patients with renal disease.

Authors:  C M Kunin; R W Chesney; W A Craig; A C England; C DeAngelis
Journal:  Pediatrics       Date:  1978-11       Impact factor: 7.124

5.  N-acetyl-beta-D-glucosaminidase (NAG) levels in amniotic fluid or urine in prenatal and postnatal life.

Authors:  S Agosti; B M Assael; P Masturzo; M R Santarone; M Salmona
Journal:  Early Hum Dev       Date:  1986-12       Impact factor: 2.079

6.  The excretion of N-acetyl-beta-glucosaminidase in glomerulonephritis.

Authors:  B Hultberg; U Ravnskov
Journal:  Clin Nephrol       Date:  1981-01       Impact factor: 0.975

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.